SCHEMBL24925547

SCHEMBL24925547

CCCOCCOCCOCCNCC(C)(C)C

nearest known ligand 0.33

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.33
KDM4E B2RXH2 2/20 0.33
RECQL P46063 1/20 0.33
LMNA P02545 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21106247 0.87 KDM4E (0.36) TSHRKDM4ERECQL
SCHEMBL26018451 0.83 HTT (0.41) TSHR
SCHEMBL25725953 0.83 HRH3 (0.31)
SCHEMBL21933642 0.83
SCHEMBL5932102 0.81 TSHR (0.43) TSHRKDM4ERECQLLMNA
SCHEMBL10959162 0.81 TSHR (0.43) TSHRKDM4ERECQLLMNA
SCHEMBL25826994 0.81 CYP2C19 (0.37) TSHRKDM4ERECQL
SCHEMBL26457722 0.81
SCHEMBL23341229 0.80 HRH3 (0.32)
SCHEMBL24763974 0.79 HRH3 (0.36)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023004163-A1 BIFUNCTIONAL COMPOUNDS FOR DEGRADING BTK WITH ENHANCED IMID ACTIVITY NURIX THERAPEUTICS, INC. (US) 2023-01-26 WO disclosed